XCHIQ: A Breakthrough in Chikungunya Prevention
IXCHIQ® is the world’s first single‑dose, live‑attenuated chikungunya vaccine approved for adults 18+, offering robust protection...
Read moreIXCHIQ® is the world’s first single‑dose, live‑attenuated chikungunya vaccine approved for adults 18+, offering robust protection...
Read more